ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 36 for:    Recruiting, Not yet recruiting, Available Studies | "Gait Disorders, Neurologic"

Effect of Flamingo Exercises on Balance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03361449
Recruitment Status : Not yet recruiting
First Posted : December 4, 2017
Last Update Posted : April 12, 2018
Sponsor:
Information provided by (Responsible Party):
ASLIHAN UZUNKULAOGLU, Ufuk University

Brief Summary:
The aim of this study is to determine the effect of flamingo exercise on balance in patients with balance impairment due to senil osteoarthritis

Condition or disease Intervention/treatment Phase
Osteoarthritis Gait Disorders, Neurologic Other: Flamingo exercise Other: training with kinesthetic ability trainer Not Applicable

Detailed Description:
Changes in the sensory, neurological, and musculoskeletal systems in older adults affect several motor tasks,including postural balance. Also osteoarthritis contribute to this process. Older people can gain balance disorders. The flamingo balance exercise is a full lower body workout utilizing many major muscle groups. Therefore investigators aimed to determine the effect of flamingo exercise combined with kinesthetic ability trainer or alone in patients with balance impairment due to osteoarthritis

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Effect of Flamingo Exercises on Balance in Patients With Balance Impairment Due to Senile Osteoarthritis
Estimated Study Start Date : April 25, 2018
Estimated Primary Completion Date : May 30, 2018
Estimated Study Completion Date : May 30, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Group 1
training with kinesthetic ability trainer.
Other: training with kinesthetic ability trainer
training with kinesthetic ability trainer

Active Comparator: Group 2
Flamingo exercise
Other: Flamingo exercise
Flamingo exercise

Active Comparator: Group 3
training with kinesthetic ability trainer and Flamingo exercise
Other: Flamingo exercise
Flamingo exercise

Other: training with kinesthetic ability trainer
training with kinesthetic ability trainer




Primary Outcome Measures :
  1. kinesthetic ability trainer static score [ Time Frame: 4 weeks ]
    kinesthetic ability trainer static score

  2. kinesthetic ability trainer static dynamic score [ Time Frame: 4 weeks ]
    kinesthetic ability trainer static dynamic score

  3. Berg Balance Scale [ Time Frame: 4 weeks ]
    a scale for balance

  4. Timed up and Go test [ Time Frame: 4 weeks ]
    for balance and gait

  5. activity specific balance scale. [ Time Frame: 4 weeks ]
    for balance



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years to 95 Years   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Older than 65 years old
  • osteoarthritis diagnosis
  • Balance impairment (Berg balance scale 21-40 points)

Exclusion Criteria:

  • Severe neurological deficit
  • Defect of vision
  • Vitamin B12 deficiency
  • Sedative drug use

Responsible Party: ASLIHAN UZUNKULAOGLU, Ufuk University Faculty of Medicine Ethical Comitee, Ufuk University
ClinicalTrials.gov Identifier: NCT03361449     History of Changes
Other Study ID Numbers: 30112015-7
First Posted: December 4, 2017    Key Record Dates
Last Update Posted: April 12, 2018
Last Verified: April 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Osteoarthritis
Gait Disorders, Neurologic
Nervous System Diseases
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neurologic Manifestations
Signs and Symptoms